Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

712 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Concentration of tissue angiotensin II increases with severity of experimental pancreatitis.
Furukawa H, Shinmura A, Tajima H, Tsukada T, Nakanuma S, Okamoto K, Sakai S, Makino I, Nakamura K, Hayashi H, Oyama K, Inokuchi M, Nakagawara H, Miyashita T, Fujita H, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Ohta T, Wakayama T, Iseki S. Furukawa H, et al. Among authors: tajima h. Mol Med Rep. 2013 Aug;8(2):335-8. doi: 10.3892/mmr.2013.1509. Epub 2013 Jun 6. Mol Med Rep. 2013. PMID: 23754456
Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma.
Okamoto K, Tajima H, Nakanuma S, Sakai S, Makino I, Kinoshita J, Hayashi H, Nakamura K, Oyama K, Nakagawara H, Fujita H, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Harada S, Wakayama T, Iseki S, Ohta T. Okamoto K, et al. Among authors: tajima h. Int J Oncol. 2012 Aug;41(2):573-82. doi: 10.3892/ijo.2012.1499. Epub 2012 May 29. Int J Oncol. 2012. PMID: 22664794 Free article.
Increased E-selectin in hepatic ischemia-reperfusion injury mediates liver metastasis of pancreatic cancer.
Yoshimoto K, Tajima H, Ohta T, Okamoto K, Sakai S, Kinoshita J, Furukawa H, Makino I, Hayashi H, Nakamura K, Oyama K, Inokuchi M, Nakagawara H, Itoh H, Fujita H, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Wakayama T, Iseki S, Shimizu K. Yoshimoto K, et al. Among authors: tajima h. Oncol Rep. 2012 Sep;28(3):791-6. doi: 10.3892/or.2012.1896. Epub 2012 Jul 3. Oncol Rep. 2012. PMID: 22766603 Free PMC article.
Neoadjuvant chemotherapy with gemcitabine for pancreatic cancer increases in situ expression of the apoptosis marker M30 and stem cell marker CD44.
Tajima H, Ohta T, Kitagawa H, Okamoto K, Sakai S, Kinoshita J, Makino I, Furukawa H, Hayashi H, Nakamura K, Oyama K, Inokuchi M, Nakagawara H, Fujita H, Takamura H, Ninomiya I, Fushida S, Tani T, Fujimura T, Kitamura S, Ikeda H, Tsuneyama K. Tajima H, et al. Oncol Lett. 2012 Jun;3(6):1186-1190. doi: 10.3892/ol.2012.657. Epub 2012 Mar 26. Oncol Lett. 2012. PMID: 22783415 Free PMC article.
Serum cytokeratin 18 as a biomarker for gastric cancer.
Oyama K, Fushida S, Kinoshita J, Okamoto K, Makino I, Nakamura K, Hayashi H, Inokuchi M, Nakagawara H, Tajima H, Fujita H, Takamura H, Ninomiya I, Kitagawa H, Fujimura T, Ohta T. Oyama K, et al. Among authors: tajima h. Clin Exp Med. 2013 Nov;13(4):289-95. doi: 10.1007/s10238-012-0202-9. Epub 2012 Jul 24. Clin Exp Med. 2013. PMID: 22825587
Pilot study of neoadjuvant chemotherapy with gemcitabine and oral S-1 for resectable pancreatic cancer.
Tajima H, Ohta T, Kitagawa H, Okamoto K, Sakai S, Makino I, Kinoshita J, Furukawa H, Nakamura K, Hayashi H, Oyama K, Inokuchi M, Nakagawara H, Fujita H, Takamura H, Ninomiya I, Fushida S, Tani T, Fujimura T, Ikeda H, Kitamura S. Tajima H, et al. Exp Ther Med. 2012 May;3(5):787-792. doi: 10.3892/etm.2012.482. Epub 2012 Feb 13. Exp Ther Med. 2012. PMID: 22969969 Free PMC article.
712 results